Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Benchmark: BSE Healthcare TRI · Riskometer: Very High
₹653.6135
NAV (2026-08-31)
₹9,479.076 Cr
AUM (2026-08-31)
0.99%
EXPENSE RATIO (DIRECT)
2004-05-10
INCEPTION
Punji Fund Health Score - percentile-within-category. See methodology.
CHART
Rolling CAGR by holding period - min, median, max
Each group is one holding-period length. Full range of outcomes across every overlapping window in the fund's history, not one trailing number.
| Metric | Value | Percentile | Category median |
|---|---|---|---|
| 3Y Rolling CAGR | 19.9% | 66.67th | 19.8% |
| 3Y Sharpe Ratio | 0.97 | 88.89th | 0.79 |
| 3Y Alpha | -1.4% | 11.11th | 3.2% |
| 3Y Std Deviation | 13.5% | 88.89th (lower is better) | 15.8% |
0.9667
1.432
-1.3882
0.864
13.4892
-14.7246
87.5808
89.0919
4.2061
Tracking Error (%)
1.3535
3-year window vs. BSE Healthcare TRI.
CHART
Top sector holdings
Share of portfolio (% to NAV) in each of the top sectors.
TOP HOLDINGS
Funds that behave most similarly (beta, capture ratios, volatility - not holdings overlap). Pick up to 2 to compare alongside this fund:
26.8534
12.4722
1.2654
62.85
CHART
Asset Allocation
As of Jul-2026
CHART
Market Cap Split
As of Jul-2026
Portfolio analytics as of Jul-2026.
Data as of 2026-09-02. Source: AMFI disclosures via Punji. Not investment advice.